Validating MeDIP by qPCR
Posted 11 September 2011 - 12:28 PM
I am carrying out MeDIP which may be followed by sequencing on SOLiD platform. Before taking it to SOLiD platform, as is necessary, I would be carrying out qPCR to validate and calculate the enrichment.
The question is, what should be the way to do this validation. What I know is that (similar to ChIP) we do delta delta Ct calculation. I am a little confused as to should this be between Input and MeDIP samples or between MeDIP and mock IP?
Also, is there any method we can quantify the percentage of DNA recovered after IP (except nanodrop)
A brief introduction to ACTUALLY what should we and what we can analyze after MeDIP through qPCR would be really appreciated
Posted 12 September 2011 - 03:50 AM
Posted 12 September 2011 - 04:17 AM
Thanks for the reply and useful suggestions. I have a panel of genes/loci which I will be using for validation. RASSF1a, H19, PWS-SRO and GAPDH as "negative control". My question is, what will be the suitable calculation methods after carrying out this analysis. The matter which is confusing me is that should the starting quantity of DNA for qPCR be same for both input and MeDIP fractions? If not, as is suggested in the protocol I have, how can we normalize the MeDIP fraction with input (which is way higher in starting quantity than MeDIP fraction).
My understanding regarding what we ACTUALLY need to prove by this validation is, that firstly we have to prove that MeDIP is specific for methylated fragments. This will be proved by amplification/non-amplification of methylated and non-methylated fragments. Secondly, we need to prove it sensitivity. Say we have a region which is almost 100% methylated and then there is a region where around 20% of CpGs are methylated in the target fragment. We need to show that MeDIP successfully, though may be differentialy, pulls down 100% and 20% methylated regions. I am stuck, how can we do that.
Posted 12 September 2011 - 05:30 AM
be very careful using GAPDH as a negative control. We found it to be partially methylated (and enriched) in CaP using MeDIP.
About the starting quantity: yes it should be the same (we just used NanoDrop).
About the sensitivity: in the literature you can find examples that will tell you (Weber et al, Nature 2005 I think and subsequent papers) how well MeDIP pulls down specific methylated fragments in relation to the CpG content. I have not seen specific assays to validate the MeDIP procedure for that though.
You could use PCR fragments with known CpG content, methylate them, enrich them and QPCR them. Just a thought.